• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于口服给药的聚合物生物材料和脂质基纳米颗粒

Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.

作者信息

Dilnawaz Fahima

机构信息

Laboratory of Nanomedicine, Institute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, Odisha, India.

出版信息

Curr Med Chem. 2017;24(22):2423-2438. doi: 10.2174/0929867323666161028160004.

DOI:10.2174/0929867323666161028160004
PMID:27804879
Abstract

BACKGROUND

Oral drug delivery is widespread owing to its non-invasive nature which complements high patient compliance. However, the drug administration via oral route is quite challenging due to the presence of the biochemical barriers which hinders the uptake as well as access to blood stream. Apart from that, stability, poor solubility and bioavailability of administered drug via the gastrointestinal (GI) tract are also exigent. Till now various oral formulations were developed which releases the drug in a timely manner but lacks appropriate therapeutic concentration.

OBJECTIVE

Recently nanoparticles based drug delivery system has emerged as prominent strategy for optimizing the oral drug delivery and maximizing the treatment efficiency. Besides, different strategic polymeric nanoparticles are engineered for interaction both at extracellular and intracellular levels with gastrointestinal mucosa.

METHODS

The review article focuses on the polymeric and lipid based various nanocarriers that have been widely studied for the enhanced oral drug delivery of different therapeutic molecules and addresses recent progress of biocompatible and biodegradable polymeric nanoparticles approach for its improvement.

CONCLUSION

The progress of numerous oral nanoparticulate drug delivery vehicles will be immensely helpful to improve therapeutic efficacy with reduced adverse side effects. Unlike other forms of administration, it will have better patient compliance and soothing effect. The oral drug delivery will certainly play a pivotal role soon in expanding the clinical repertoire and applications.

摘要

背景

口服给药因其非侵入性而广泛应用,这有助于提高患者的依从性。然而,由于存在生化屏障,阻碍药物吸收并进入血流,口服给药颇具挑战性。除此之外,经胃肠道给药的药物稳定性差、溶解度低和生物利用度低等问题也很突出。到目前为止,已开发出各种口服制剂,这些制剂能及时释放药物,但缺乏合适的治疗浓度。

目的

近年来,基于纳米颗粒的药物递送系统已成为优化口服药物递送和提高治疗效率的重要策略。此外,还设计了不同的策略性聚合物纳米颗粒,使其在细胞外和细胞内水平与胃肠道黏膜相互作用。

方法

这篇综述文章重点介绍了基于聚合物和脂质的各种纳米载体,这些纳米载体已被广泛研究用于增强不同治疗分子的口服药物递送,并阐述了生物相容性和可生物降解聚合物纳米颗粒方法在这方面的最新进展。

结论

众多口服纳米颗粒药物递送载体的进展将极大地有助于提高治疗效果并减少不良反应。与其他给药形式不同,它将具有更好的患者依从性和舒缓效果。口服药物递送肯定会在不久的将来在扩大临床应用范围和应用方面发挥关键作用。

相似文献

1
Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.用于口服给药的聚合物生物材料和脂质基纳米颗粒
Curr Med Chem. 2017;24(22):2423-2438. doi: 10.2174/0929867323666161028160004.
2
Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.作为基因载体的生物相容性和可生物降解纳米粒子的最新进展。
Expert Opin Biol Ther. 2016 Jun;16(6):771-85. doi: 10.1517/14712598.2016.1169269. Epub 2016 Apr 4.
3
Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?纳米结构脂质载体、固体脂质纳米粒和聚合物纳米粒:哪种药物递送系统对胶质母细胞瘤化疗效果更佳?
Drug Deliv. 2016 Nov;23(9):3408-3416. doi: 10.1080/10717544.2016.1189465. Epub 2016 Jun 8.
4
Lipid-based nanocarriers for the oral administration of biopharmaceutics.基于脂质的纳米载体用于口服生物药剂学。
Nanomedicine (Lond). 2016 Nov;11(22):3009-3032. doi: 10.2217/nnm-2016-0265. Epub 2016 Oct 26.
5
Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.基于聚合物的纳米粒用于口服胰岛素传递:再探讨的方法。
Biotechnol Adv. 2015 Nov 1;33(6 Pt 3):1342-54. doi: 10.1016/j.biotechadv.2015.02.010. Epub 2015 Feb 26.
6
Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.脂质聚合物杂化物作为用于口服给药的纳米载体中的新兴工具。
Artif Cells Nanomed Biotechnol. 2016;44(1):334-49. doi: 10.3109/21691401.2014.951721. Epub 2014 Sep 19.
7
Nanocarriers for oral drug delivery.纳米载体用于口服药物递送。
J Drug Target. 2013 Jul;21(6):515-27. doi: 10.3109/1061186X.2013.789033. Epub 2013 Apr 26.
8
Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.聚合物颗粒技术用于口服药物传递和靶向给药:病理生理学视角。
Nanomedicine. 2012 Sep;8 Suppl 1:S5-20. doi: 10.1016/j.nano.2012.07.005. Epub 2012 Jul 27.
9
Exploitation of lipid-polymeric matrices at nanoscale for drug delivery applications.纳米级脂质聚合物基质在药物传递应用中的开发。
Expert Opin Drug Deliv. 2016 Sep;13(9):1301-9. doi: 10.1080/17425247.2016.1182492. Epub 2016 May 11.
10
pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.pH 敏感型聚合物纳米粒提高肽/蛋白类药物和难溶性药物的口服生物利用度。
Eur J Pharm Biopharm. 2012 Oct;82(2):219-29. doi: 10.1016/j.ejpb.2012.07.014. Epub 2012 Aug 3.

引用本文的文献

1
Improved Biopharmaceutical Performance of Coenzyme Q10 Through Solid Lipid Nanoparticles for Enhanced Brain Delivery.通过固体脂质纳米粒改善辅酶Q10的生物制药性能以增强脑部递送
Scientifica (Cairo). 2025 Jun 16;2025:9034181. doi: 10.1155/sci5/9034181. eCollection 2025.
2
Recent development of micro-nano carriers for oral antineoplastic drug delivery.用于口服抗肿瘤药物递送的微纳米载体的最新进展。
Mater Today Bio. 2025 Jan 3;30:101445. doi: 10.1016/j.mtbio.2025.101445. eCollection 2025 Feb.
3
Nebulized milk exosomes loaded with siTGF-β1 ameliorate pulmonary fibrosis by inhibiting EMT pathway and enhancing collagen permeability.
雾化载有 siTGF-β1 的牛奶外泌体通过抑制 EMT 通路和增强胶原通透性来改善肺纤维化。
J Nanobiotechnology. 2024 Jul 23;22(1):434. doi: 10.1186/s12951-024-02721-z.
4
Cracking the intestinal lymphatic system window utilizing oral delivery vehicles for precise therapy.利用口服递药系统破解肠道淋巴系统窗口,实现精准治疗。
J Nanobiotechnology. 2023 Aug 10;21(1):263. doi: 10.1186/s12951-023-01991-3.
5
Changes of physico-chemical properties of nano-biomaterials by digestion fluids affect the physiological properties of epithelial intestinal cells and barrier models.消化液对纳米生物材料理化性质的改变会影响肠道上皮细胞和屏障模型的生理特性。
Part Fibre Toxicol. 2022 Jul 19;19(1):49. doi: 10.1186/s12989-022-00491-w.
6
Evolutionary approaches in protein engineering towards biomaterial construction.用于生物材料构建的蛋白质工程中的进化方法。
RSC Adv. 2019 Oct 29;9(60):34720-34734. doi: 10.1039/c9ra06807d. eCollection 2019 Oct 28.
7
The Optimized Delivery of Triterpenes by Liposomal Nanoformulations: Overcoming the Challenges.脂质体纳米制剂优化三萜类化合物的递送:克服挑战。
Int J Mol Sci. 2022 Jan 20;23(3):1140. doi: 10.3390/ijms23031140.
8
Supramolecular lipid nanoparticles as delivery carriers for non-invasive cancer theranostics.超分子脂质纳米颗粒作为非侵入性癌症诊疗的递送载体
Curr Res Pharmacol Drug Discov. 2021 Oct 28;2:100067. doi: 10.1016/j.crphar.2021.100067. eCollection 2021.
9
Biocompatible and Biomaterials Application in Drug Delivery System in Oral Cavity.生物相容性及生物材料在口腔给药系统中的应用
Evid Based Complement Alternat Med. 2021 Nov 13;2021:9011226. doi: 10.1155/2021/9011226. eCollection 2021.
10
Oral Efficacy of a Diselenide Compound Loaded in Nanostructured Lipid Carriers in a Murine Model of Visceral Leishmaniasis.载纳米结构脂质载体二硒化物化合物在内脏利什曼病小鼠模型中的口服疗效。
ACS Infect Dis. 2021 Dec 10;7(12):3197-3209. doi: 10.1021/acsinfecdis.1c00394. Epub 2021 Nov 12.